Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises ALAFCO in connection with leasing of 4 brand new Airbus A320-NEO to SAS, delivered by Airbus from a production facility in Hamburg
Mandate

Vinge advises ALAFCO in connection with leasing of 4 brand new Airbus A320-NEO to SAS, delivered by Airbus from a production facility in Hamburg

February 03, 2021

Vinge has advised ALAFCO Aviation Lease and Finance Company, a Kuwait based, world leading operator in the airplane leasing business, in connection with the lease of 4 Airbus A320-NEOs, the new, more fuel-efficient narrow-body airplane, to Scandinavian Airlines System Denmark-Norway-Sweden (SAS).

Vinge has also managed the registration of all these new airplanes at the Swedish Transport Authority in the Aircraft Register and collaborated with international law firms as regards registration security rights in the International Aircraft Register which is maintained in Dublin according to the Cape Town Convention.

Vinge’s team consisted of partner, Fredrik Wilkens, together with Henrik Schön, Project Manager, as well as Anton Sjökvist and Elias Bohlin.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025